Charles Eden

Stock Analyst at UBS

(2.20)
# 3,163
Out of 5,073 analysts
281
Total ratings
51.7%
Success rate
0.5%
Average return

Stocks Rated by Charles Eden

Symrise AG
Jun 18, 2026
Reiterated: Buy
Price Target: €94.00
Current: €101.00
Upside: -6.93%
Givaudan SA
Jun 12, 2026
Reiterated: Hold
Price Target: CHF 3,100 → CHF 3,270
Current: CHF 3,962
Upside: -17.47%
Softcare Limited
May 27, 2026
Reiterated: Buy
Price Target: $42.20
Current: $25.96
Upside: +62.56%
DSM-Firmenich AG
May 8, 2026
Reiterated: Buy
Price Target: €85.00 → €86.00
Current: €107.85
Upside: -20.26%
Wacker Chemie AG
Apr 29, 2026
Reiterated: Buy
Price Target: €84.00
Current: €86.60
Upside: -3.00%
Air Liquide S.A.
Apr 28, 2026
Reiterated: Buy
Price Target: €190.89
Current: €173.60
Upside: +9.96%
Croda International Plc
Apr 23, 2026
Reiterated: Buy
Price Target: 4,300p
Current: 3,625p
Upside: +18.62%
Essity AB (publ)
Apr 10, 2026
Reiterated: Buy
Price Target: kr 310.00 → kr 290.00
Current: kr 276.50
Upside: +4.88%
Novozymes A/S
Feb 14, 2024
Reiterated: Hold
Price Target: $59
Current: $70.11
Upside: n/a
Elementis plc
Sep 21, 2023
Reiterated: Buy
Price Target: 140p
Current: 183p
Upside: n/a
Reiterated: Sell
Price Target: €89.00 → €85.00
Current: €81.06
Upside: n/a
Downgraded: Sell
Price Target: €71.00 → €58.00
Current: €60.82
Upside: n/a
Reiterated: Buy
Price Target: €252.00 → €310.00
Current: €405.70
Upside: n/a
Reiterated: Sell
Price Target: €62.00
Current: €78.04
Upside: n/a
Reiterated: Buy
Price Target: CHF 117.00 → CHF 105.00
Current: CHF 83.47
Upside: n/a
Reiterated: Hold
Price Target: 6,500p → 5,700p
Current: 5,430p
Upside: n/a
Reiterated: Hold
Price Target: 4,850p → 4,150p
Current: 4,820p
Upside: n/a
Initiated Coverage: Buy
Price Target: n/a
Current: $275.50
Upside: n/a
Upgraded: Hold
Price Target: n/a
Current: $0.201
Upside: n/a
Initiated Coverage: Hold
Price Target: $51
Current: $105.00
Upside: n/a
Initiated Coverage: Sell
Price Target: $124
Current: $106.64
Upside: n/a
Upgraded: Buy
Price Target: n/a
Current: $84.77
Upside: n/a
Initiated Coverage: Buy
Price Target: $102
Current: $103.66
Upside: n/a